Market Cap 38.07M
Revenue (ttm) 0.00
Net Income (ttm) -29.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 350,140
Avg Vol 703,506
Day's Range N/A - N/A
Shares Out 46.74M
Stochastic %K 5%
Beta 0.11
Analysts Strong Sell
Price Target $9.43

Latest News on RVPH

Reviva to Participate in the 2025 BIO CEO & Investor Conference

Jan 30, 2025, 8:00 AM EST - 4 months ago

Reviva to Participate in the 2025 BIO CEO & Investor Conference


Reviva Announces Proposed Public Offering

Dec 16, 2024, 5:18 PM EST - 6 months ago

Reviva Announces Proposed Public Offering


Reviva to Participate in the UBS Global Healthcare Conference

Oct 31, 2024, 8:00 AM EDT - 7 months ago

Reviva to Participate in the UBS Global Healthcare Conference


Reviva to Participate in the BIO International Convention

May 21, 2024, 8:00 AM EDT - 1 year ago

Reviva to Participate in the BIO International Convention


Reviva to Present at the UBS Virtual CNS Day

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present at the UBS Virtual CNS Day


Reviva to Present at the 36th Annual ROTH Conference

Mar 7, 2024, 8:00 AM EST - 1 year ago

Reviva to Present at the 36th Annual ROTH Conference